We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Phaxiam Therapeutics | LSE:0QSS | London | Ordinary Share | FR001400K4B1 | PHAXIAM THERAPEUTICS ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 71.025 | 6.925 | 7.28 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.33M | -23.49M | -3.8663 | -0.44 | 431.48M |
Date | Time | Source | Headline |
---|---|---|---|
05/12/2024 | 17:00 | UKREG | PHAXIAM Therapeutics : information mensuelle relative au nombre total de.. |
05/12/2024 | 17:00 | UKREG | PHAXIAM Therapeutics : monthly information related to total number of.. |
27/11/2024 | 13:30 | UKREG | PHAXIAM Therapeutics presents an ambitious development strategy to take.. |
27/11/2024 | 13:30 | UKREG | PHAXIAM présente une stratégie de développement ambitieuse pour tirer parti.. |
18/11/2024 | 17:00 | UKREG | PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility.. |
18/11/2024 | 17:00 | UKREG | PHAXIAM a présenté son test IVD Phagogramme et l’actualisation du suivi de.. |
13/11/2024 | 16:45 | UKREG | PHAXIAM Reports Third-Quarter 2024 Financial Information |
13/11/2024 | 16:45 | UKREG | PHAXIAM publie l’information financière du troisième trimestre 2024 |
08/11/2024 | 17:00 | UKREG | Monthly information related to total number of voting rights and shares.. |
08/11/2024 | 17:00 | UKREG | Information mensuelle relative au nombre total de droits de vote et.. |
1 Year Phaxiam Therapeutics Chart |
Intraday Phaxiam Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions